Jeffrey B. Arterburn

8.8k citations

88 papers · 7.3k indexed · 3 hit papers · h-index 36

Genetics top 0.2%
Molecular Biology top 2%
Endocrinology, Diabetes and Metabolism top 0.5%
Organic Chemistry top 2%
Oncology top 5%

Co-authors: Eric R. Prossnitz Larry A. Sklar Chetana M. Revankar Daniel F. Cimino Tudor I. Oprea Helen J. Hathaway Chinnasamy Ramesh Cristian Bologa
Topics: Estrogen and related hormone effects (33 papers)Receptor Mechanisms and Signaling (20 papers)Radiopharmaceutical Chemistry and Applications (17 papers)
Cited by: Genetics Endocrinology, Diabetes and Metabolism Behavioral Neuroscience
Journals: Science Journal of the American Chemical Society Angewandte Chemie International Edition
Partner nations: United States Denmark Switzerland

In The Last Decade

Jeffrey B. Arterburn

87 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling

2005 1.9k citations Chetana M. Revankar, Larry A. Sklar et al. profile →
Virtual and biomolecular screening converge on a selective agonist for GPR30

2006 692 citations Cristian Bologa, Chetana M. Revankar et al. Nature Chemical Biology profile →
Estrogen Signaling through the Transmembrane G Protein–Coupled Receptor GPR30

2008 501 citations Eric R. Prossnitz, Jeffrey B. Arterburn et al. profile →

Peers

Countries citing papers authored by Jeffrey B. Arterburn

Since Specialization

Citations

This map shows the geographic impact of Jeffrey B. Arterburn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey B. Arterburn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey B. Arterburn more than expected).

Fields of papers citing papers by Jeffrey B. Arterburn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey B. Arterburn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey B. Arterburn. The network helps show where Jeffrey B. Arterburn may publish in the future.

Co-authorship network of co-authors of Jeffrey B. Arterburn

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey B. Arterburn. A scholar is included among the top collaborators of Jeffrey B. Arterburn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey B. Arterburn. Jeffrey B. Arterburn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes 2020 ·Science Translational Medicine ·Geetanjali Sharma,Chelin Hu,Daniela I. Staquicini,Jonathan L. Brigman,Meilian Liu,Franck Mauvais‐Jarvis,Renata Pasqualini,Wadih Arap,Jeffrey B. Arterburn,Helen J. Hathaway,Eric R. Prossnitz	74
2	Old Drugs with New Tricks: Efficacy of Fluoroquinolones to Suppress Replication of Flaviviruses 2020 ·Viruses ·(unknown),(unknown),Chinnasamy Ramesh,Sasha R. Azar,Erin E. Schirtzinger,(unknown),Jeffrey B. Arterburn,Kathryn A. Hanley,Shannan L. Rossi	12
3	Evolution of resistance to fluoroquinolones by dengue virus serotype 4 provides insight into mechanism of action and consequences for viral fitness 2020 ·Virology ·(unknown),(unknown),Chinnasamy Ramesh,Steven G. Widen,Sasha R. Azar,Shannan L. Rossi,Jeffrey B. Arterburn,Nikos Vasilakis,Kathryn A. Hanley	8
4	Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy 2016 ·PLoS ONE ·(unknown),Barbara Yang,(unknown),(unknown),William DeMaio,(unknown),Chinnasamy Ramesh,Jeffrey B. Arterburn,Ruth G. Perez	8
5	GPER-Targeted, 99mTc-Labeled, Nonsteroidal Ligands Demonstrate Selective Tumor Imaging and In Vivo Estrogen Binding 2014 ·Molecular Cancer Research ·Tapan K. Nayak,Chinnasamy Ramesh,Helen J. Hathaway,Jeffrey P. Norenberg,Jeffrey B. Arterburn,Eric R. Prossnitz	9
6	G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth 2013 ·Obstetrics and Gynecology International ·Whitney K. Petrie,Megan K. Dennis,Chelin Hu,Donghai Dai,Jeffrey B. Arterburn,Harriet O. Smith,Helen J. Hathaway,Eric R. Prossnitz	141
7	Synthesis and Characterization of Tricarbonyl-Re/Tc(I) Chelate Probes Targeting the G Protein-Coupled Estrogen Receptor GPER/GPR30 2012 ·PLoS ONE ·Ritwik Burai,Chinnasamy Ramesh,Tapan K. Nayak,Megan K. Dennis,(unknown),Eric R. Prossnitz,Jeffrey B. Arterburn	21
8	Bradycardic effects mediated by activation of G protein‐coupled estrogen receptor in rat nucleus ambiguus 2012 ·Experimental Physiology ·G. Cristina Brailoiu,Jeffrey B. Arterburn,Tudor I. Oprea,Vineet C. Chitravanshi,Eugen Brailoiu	23
9	GPR30 Expression Is Required for the Mineralocorticoid Receptor–Independent Rapid Vascular Effects of Aldosterone 2011 ·Hypertension ·Robert Gros,Qingming Ding,Larry A. Sklar,Eric R. Prossnitz,Jeffrey B. Arterburn,Jozef Chorazyczewski,Ross D. Feldman	196
10	The G Protein–Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor–Positive Breast Cancer Cells 2010 ·Cancer Research ·Eric A. Ariazi,Eugen Brailoiu,Smitha Yerrum,(unknown),Michael Slifker,Heather E. Cunliffe,Michael A. Black,Anne L. Donato,Jeffrey B. Arterburn,Tudor I. Oprea,Eric R. Prossnitz,Nae J. Dun,V. Craig Jordan	204
11	A novel nucleoside analog, 1-β-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro 2010 ·Antiviral Research ·Michael M. McDowell,(unknown),(unknown),(unknown),Jeffrey B. Arterburn,Kathryn A. Hanley	35
12	Synthesis and anti-Hantaan virus activity of N1-3-fluorophenyl-inosine 2009 ·Antiviral Research ·Donghoon Chung,J. Jacob Strouse,Yanjie Sun,Jeffrey B. Arterburn,William B. Parker,Colleen B. Jonsson	11
13	Expression of estrogen receptor GPR30 in the rat spinal cord and in autonomic and sensory ganglia 2009 ·Journal of Neuroscience Research ·Siok L. Dun,G. Cristina Brailoiu,Xīn Gào,Eugen Brailoiu,Jeffrey B. Arterburn,Eric R. Prossnitz,Tudor I. Oprea,Nae J. Dun	83
14	Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate^99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers 2008 ·Journal of Nuclear Medicine ·Tapan K. Nayak,Helen J. Hathaway,Chinnasamy Ramesh,Jeffrey B. Arterburn,Donghai Dai,Larry A. Sklar,Jeffrey P. Norenberg,Eric R. Prossnitz	41
15	The ins and outs of GPR30: A transmembrane estrogen receptor 2008 ·The Journal of Steroid Biochemistry and Molecular Biology ·Eric R. Prossnitz,Tudor I. Oprea,Larry A. Sklar,Jeffrey B. Arterburn	125
16	Structural effects on the phosphorylation of 3-substituted 1-β-d-ribofuranosyl-1,2,4-triazoles by human adenosine kinase 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Yanjie Sun,(unknown),(unknown),William B. Parker,Colleen B. Jonsson,Jeffrey B. Arterburn	13
17	GPR30: A G protein-coupled receptor for estrogen 2007 ·Molecular and Cellular Endocrinology ·Eric R. Prossnitz,Jeffrey B. Arterburn,Larry A. Sklar	240
18	Characterization of a Radiolabeled Small Molecule Targeting Leukocyte Function–Associated Antigen-1 Expression in Lymphoma and Leukemia 2006 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown),Jeffrey P. Norenberg,Tamara L. Anderson,Jack L. Erion,Carston R. Wagner,Jeffrey B. Arterburn,Richard A. Larson	5
19	Virtual and biomolecular screening converge on a selective agonist for GPR30breakdown → 2006 ·Nature Chemical Biology ·Cristian Bologa,Chetana M. Revankar,Susan Young,Bruce S. Edwards,Jeffrey B. Arterburn,Alexander S. Kiselyov,Matthew A. Parker,Sergey E. Tkachenko,(unknown),Larry A. Sklar,Tudor I. Oprea,Eric R. Prossnitz	692
20	Synthesis of (pyridin-2-yl)hydrazine conjugates as bifunctional chelates using the Suzuki–Miyaura reaction 2003 ·Chemical Communications ·Jeffrey B. Arterburn,(unknown),(unknown)	7

About Jeffrey B. Arterburn

Jeffrey B. Arterburn is a scholar working on Genetics, Organic Chemistry and Virology, having authored 88 papers that have together received 7.3k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (33 papers), Receptor Mechanisms and Signaling (20 papers) and Radiopharmaceutical Chemistry and Applications (17 papers). The work is most often cited by research in Genetics (4.1k citations), Endocrinology, Diabetes and Metabolism (1.8k citations) and Behavioral Neuroscience (299 citations). Jeffrey B. Arterburn has collaborated with scholars based in United States, Denmark and Switzerland. Frequent co-authors include Eric R. Prossnitz, Larry A. Sklar, Chetana M. Revankar, Daniel F. Cimino, Tudor I. Oprea, Helen J. Hathaway, Chinnasamy Ramesh, Cristian Bologa, Harriet O. Smith and Marc C. Perry. Their work appears in journals such as Science, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact